Skip to content
777 Sourcing.

Capability

RNA immunotherapy development

Suppliers
1
States & provinces
1
Countries
1

1 rna immunotherapy development supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

CAROGEN CORP

HAMDEN, CT

CaroGen Corporation is a Yale School of Medicine spin-out based in Farmington, Connecticut, developing a functional cure for chronic hepatitis B. Its lead candidate CARG-201 is a replicating RNA immunotherapy built on the AVIDIO™ virus-like vesicle (VLV) platform, currently advancing through Phase 1/1b under IND 31717. The company holds U.S. Patent No. 12,577,585 and has received ~$11.0M in NIH and DoD grants.

clinical developmentdrug discovery and IND-enabling studiesGMP manufacturing oversight

Compiled from public sources

Related capabilities

Other processes offered by the shops that list RNA immunotherapy development.

Browse all capabilities